Elsevier has launched LeapSpace, a next-generation AI-assisted workspace designed to transform how academic and corporate scientists conduct research. The platform integrates the largest collection of peer-reviewed scientific content with responsible AI to support faster discovery and collaboration.

LeapSpace builds on Elsevier’s ScienceDirect AI and Scopus AI, combining millions of full-text articles, books, and research abstracts from leading publishers. The platform includes innovative Trust Cards, which provide transparency into every AI-generated result, helping researchers assess the strength of evidence and identify contradictions.

“LeapSpace enables researchers to move from curiosity to discovery without leaving trusted ground,” Judy Verses, president, academic and government, Elsevier, said. “By combining an unparalleled body of peer-reviewed research with responsible AI, we’re supporting the research community to build on the strongest foundations of trusted knowledge to advance human progress.”

Unlike general-purpose AI tools that rely on unverified web content, LeapSpace only draws from verified scientific sources. Its content set includes the world’s largest collection of research abstracts, over 15 million peer-reviewed full-text articles and books from Elsevier and other publishers, and access to Scopus, Elsevier’s publisher-neutral database of over 100 million records from 7,000 global publishers. An independent advisory board ensures the platform’s algorithms remain explainable and publisher-neutral.

LeapSpace is purpose-built for researchers. It allows users to generate ideas, plan projects, explore literature, find collaborators, and identify funding opportunities in a secure environment. Features include Deep Research reports highlighting emerging patterns, Reading Assistant, Compare, Author Search, and the ability to upload personal content for enriched analysis. Funding discovery integrates 45,000 active and recurring grants worth over $100 billion from Elsevier’s Funding Institutional database. Enterprise-grade security ensures responsible AI use and data privacy in line with Elsevier’s privacy principles.

Thousands of researchers from 300 institutions in 64 countries helped develop and test LeapSpace. Early users report time savings, improved research design, and deeper insights. Cara O’Neill MD, FAAP, chief science officer, Cure Sanfilippo Foundation, said: “Rare disease research is limited by the small number of experts focused on each disease, Sanfilippo syndrome being no exception. Synthesizing vast amounts of often disparate information is a challenge. In my early experience with LeapSpace, I’ve been impressed with how it’s able to address these challenges while providing confidence in the accuracy and rigor of its outputs.”

LeapSpace is available for institutional preview today, with existing and new ScienceDirect AI customers automatically upgraded when the platform becomes commercially available in Q1 2026.